...
首页> 外文期刊>Neurosurgical review. >Risk factors for new-onset shunt-dependency after craniotomies for intracranial tumors in adult patients
【24h】

Risk factors for new-onset shunt-dependency after craniotomies for intracranial tumors in adult patients

机译:成人患者颅内肿瘤颅内依赖新生病分流依赖性的危险因素

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

The risk of developing a de novo shunt-dependent hydrocephalus (HC) after undergoing a craniotomy for brain tumor in adult patients is largely unknown. All craniotomies for intracranial tumors at Oslo University Hospital in adult patients aeyen18 years of age during a 10-year period (2004-2013) were included. None were lost to follow-up. Patients who developed a shunt-dependent HC were identified by cross-linking our prospectively collected tumor database to patients with a NCSP surgical procedure code of hydrocephalus (AAF). Patients with pre-existing HC or ventriculoperitoneal (VP) shunts were excluded from the study. A total of 4401 craniotomies were performed. Of these, 46 patients (1.0%) developed de novo postoperative HC requiring a VP shunt after a median of 93 days (mean 115 days, range 6-442). Median age was 62.0 years (mean 58.9 years, range 27.3-80.9) at time of VP shunt surgery. Patients without pre-existing HC had a 0.2% (n = 8/4401) risk of becoming VP shunt dependent within 30 days and 0.5% (n = 22/4401) within 90 days. Age, sex, tumor location, primary/secondary surgery, and radiotherapy were not associated with VP shunt dependency. Choroid plexus tumors and craniopharyngiomas had increased risk of VP shunt dependency. In this large, contemporary, single-institution consecutive series, the risk of postoperative shunt-dependency after craniotomies for brain tumors without pre-existing HC was very low. This is the largest study with regards to de novo postoperative shunt-dependency after craniotomies for patients with intracranial tumors and can serve as a benchmark for future studies.
机译:在成年患者中脑肿瘤接受脑肿瘤后开发De Novo分流依赖性脑积水(HC)的风险在很大程度上是未知的。成人患者AE奥斯陆大学医院颅内肿瘤的所有颅内肿瘤均为10年期内(2004 - 2013年)。没有人失去了随访。通过将我们的前瞻性收集的肿瘤数据库交联向患有NCSP手术程序(AAF)的NCSP手术程序代码的患者来鉴定开发分流依赖性HC的患者。患有预先存在的HC或脑室内(VP)分流的患者被排除在研究之外。共进行了4401个Craniotomies。其中46名患者(1.0%)在93天中间(平均115天,范围6-442的范围)后,46名患者(1.0%)开发了VP术后HC。在VP分流手术时,中位年龄为62.0岁(平均58.9岁,范围为27.3-80.9)。没有预先存在的HC的患者在30天内依赖于vp分流的0.2%(n = 8/4401),并且在90天内得到0.5%(n = 22/4401)。年龄,性别,肿瘤位置,初级/继发手术和放射治疗与VP分流依赖性无关。脉络膜丛肿瘤和颅咽管瘤的风险增加了VP分流依赖性。在这种大型,当代,单机制连续的系列中,术后分流依赖性在没有预先存在的HC的脑肿瘤后术后分流依赖性的风险非常低。这是对颅内肿瘤患者的Craniot术后De Novo术后分流依赖性的最大研究,并且可以作为未来研究的基准。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号